IDiyas

For the Inventor, By the Inventor

Rockville, MD, United States of America

Scott Grindrod

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Rockville, MD (US) (2017 - 2023)
  • Falls Church, VA (US) (2022 - 2024)

Company Filing History:

goldMedal9 out of 9 
 
Shuttle Pharmaceuticals, Inc.
 patents

Years Active: 2017-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12357650 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation (2025-07-15),
2. 12077515 - Selective histone deacetylase inhibitors for the treatment of human disease (2024-09-03),
3. 11654157 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation (2023-05-23),
4. 11584733 - Selective histone deacetylase inhibitors for the treatment of human disease (2023-02-21),
5. 11407723 - Selective histone deacetylase inhibitors for the treatment of human disease (2022-08-09),
6. 11034667 - Selective histone deacetylase inhibitors for the treatment of human disease (2021-06-15),
7. 10745352 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-18),
8. 10730834 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-04),
9. 9809539 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2017-11-07),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…